We are live on !
Find out more
John Paulson Paulson & Co
AUM
$2.58B
Turnover
30%
1-Year Est. Return
68.51%
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$7.53B
AUM Growth
-$400M
(-5%)
Cap. Flow
-$409M
Cap. Flow % of AUM
Cap. Flow %
-5.43%
Top 10 Holdings %
Top 10 Hldgs %
58.97%
Holding
128
New
26
Increased
14
Reduced
35
Closed
30
Avg Time Held
Equity + Options
1.3
years
Top 10 Avg Time Held
Equity + Options
1.4
years
Top 20 Avg Time Held
Equity + Options
1.5
years
Avg Time Held Equity only
1.4
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$255M |
| 2 |
DISH
DISH Network Corp.
DISH
|
+$213M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$94.9M |
| 4 |
NXP Semiconductors
NXPI
|
+$76.8M |
| 5 |
Brookdale Senior Living
BKD
|
+$71.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$168M |
| 2 |
AGN
Allergan plc
AGN
|
+$143M |
| 3 |
STAY
Extended Stay America, Inc. Paired Share Unit
STAY
|
+$142M |
| 4 |
Viatris
VTRS
|
+$134M |
| 5 |
HAR
Harman International Industries
HAR
|
+$94.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.18% |
| 2 | Communication Services | 12.37% |
| 3 | Consumer Discretionary | 11% |
| 4 | Miscellaneous | 9.68% |
| 5 | Materials | 5.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $703M | 9.33% |
2,941,834
-612,900
| -17% | -$143M |
2014 Q1
12 quarters
|
|
|
SHPG
2
DELISTED
Shire pic
SHPG
| $697M | 9.25% |
3,998,100
-208,000
| -5% | -$36.3M |
2013 Q2
15 quarters
|
|
|
3
Viatris
VTRS
$23.9B
| $674M | 8.94% |
17,274,387
-3,328,113
| -16% | -$134M |
2013 Q2
15 quarters
|
|
4
SPDR Gold Trust
GLD
$130B
| $518M | 6.87% |
4,359,722
| – | – |
2013 Q2
15 quarters
|
|
|
5
Teva Pharmaceutical Industries Limited
TEVA
$51.9B
| $353M | 4.68% |
10,997,300
-4,928,500
| -31% | -$168M |
2015 Q2
7 quarters
|
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $334M | 4.44% |
7,500,972
-475,900
| -6% | -$23.5M |
2013 Q3
14 quarters
|
|
|
STAY
7
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $319M | 4.23% |
20,086,590
-8,541,668
| -30% | -$142M |
2013 Q4
13 quarters
|
|
|
TWX
8
DELISTED
Time Warner Inc
TWX
| $295M | 3.92% |
3,024,000
+168,100
| +6% | +$16.3M |
2016 Q4
1 quarter
|
|
9
American International
AIG
$43B
| $284M | 3.77% |
4,548,593
-260,762
| -5% | -$16.7M |
2015 Q1
8 quarters
|
|
|
10
T-Mobile US
TMUS
$180B
| $267M | 3.55% |
+4,140,100
| New | +$255M |
2017 Q1
0 quarters
|
|
|
DISH
11
DELISTED
DISH Network Corp.
DISH
| $219M | 2.91% |
+3,450,100
| New | +$213M |
2017 Q1
0 quarters
|
|
12
Bausch Health
BHC
$3.13B
| $214M | 2.84% |
19,384,500
| – | – |
2014 Q1
12 quarters
|
|
|
AKRX
13
DELISTED
Akorn Inc
AKRX
| $202M | 2.68% |
8,397,100
-289,400
| -3% | -$6.3M |
2015 Q4
5 quarters
|
|
|
CACQ
14
DELISTED
Caesars Acquisition Company
CACQ
| $202M | 2.68% |
13,117,998
| – | – |
2013 Q4
13 quarters
|
|
15
DELISTED
Anywhere Real Estate
HOUS
| $143M | 1.89% |
4,785,000
| – | – |
2013 Q2
15 quarters
|
|
16
DELISTED
Caesars Entertainment Corporation
CZR
| $138M | 1.83% |
14,417,900
| – | – |
2013 Q2
15 quarters
|
|
17
AngloGold Ashanti
AU
$43.7B
| $138M | 1.83% |
12,782,400
| – | – |
2013 Q2
15 quarters
|
|
|
18
NXP Semiconductors
NXPI
$66.8B
| $117M | 1.56% |
1,132,300
+759,300
| +204% | +$76.8M |
2016 Q4
1 quarter
|
|
|
SGYP
19
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $112M | 1.49% |
24,088,655
| – | – |
2015 Q1
8 quarters
|
|
20
NovaGold Resources
NG
$2.47B
| $108M | 1.43% |
22,130,696
-141,100
| -0.6% | -$746K |
2013 Q2
15 quarters
|
|
|
MJN
21
DELISTED
Mead Johnson Nutrition Company
MJN
| $105M | 1.4% |
1,184,200
+1,153,400
| +3,745% | +$94.9M |
2016 Q3
2 quarters
|
|
22
TIM SA
TIMB
$9.07B
| $89.7M | 1.19% |
5,611,900
-63,300
| -1% | -$949K |
2014 Q2
11 quarters
|
|
|
ENDP
23
DELISTED
Endo International plc
ENDP
| $87.5M | 1.16% |
7,838,900
-1,000
| -0% | -$12.4K |
2015 Q3
6 quarters
|
|
24
Chord Energy
CHRD
$7.97B
| $73.5M | 0.98% |
5,156,544
-30,756
| -0.6% | -$433K |
2013 Q3
14 quarters
|
|
25
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $70.8M | 0.94% |
6,263,526
| – | – |
2013 Q2
15 quarters
|
|
Similar funds
CL
FFH
John Paulson's Q1 2017 Portfolio in Review
As of Q1 2017, John Paulson held 128 positions worth $7.53B, down 5% from $7.93B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
John Paulson withdrew a net $409M in Q1 2017, closing 30 positions and reducing 35 holdings. Its most notable exit was Harman International Industries, an estimated $94.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 53% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, John Paulson opened a new position in T-Mobile US worth $267M.
- John Paulson's largest Q1 2017 buy was T-Mobile US: 4,140,100 shares worth $267M.
- John Paulson added most to Mead Johnson Nutrition Company in Q1 2017, an estimated $94.9M increase.
- John Paulson's biggest Q1 2017 reduction was Teva Pharmaceutical Industries Limited, cutting an estimated $168M.
- John Paulson fully exited Harman International Industries in Q1 2017, selling an estimated $94.9M.
- John Paulson's ten largest holdings make up 59% of its $7.53B portfolio in Q1 2017.
- John Paulson opened 26 new positions and closed 30 in Q1 2017.
- John Paulson's portfolio value fell 5% quarter-over-quarter to $7.53B.
Based on Paulson & Co's 13F filing for Q1 2017, filed 15 May 2017.